Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial
about
Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anatabine supplementation decr ...... ized controlled clinical trial
@en
Anatabine supplementation decr ...... chronic lymphocytic autoimmune
@nl
type
label
Anatabine supplementation decr ...... ized controlled clinical trial
@en
Anatabine supplementation decr ...... chronic lymphocytic autoimmune
@nl
prefLabel
Anatabine supplementation decr ...... ized controlled clinical trial
@en
Anatabine supplementation decr ...... chronic lymphocytic autoimmune
@nl
P2093
P2860
P356
P1476
Anatabine supplementation decr ...... ized controlled clinical trial
@en
P2093
Amy E Cohen
Barry S Horowitz
Curtis Wright
Jonathan D Leffert
Kerem Ozer
Lowell R Schmeltz
Marc A Goldberg
Pedro Troya
Richard H Bertenshaw
Ryan K Lanier
P2860
P304
P356
10.1210/JC.2013-2951
P407
P577
2013-12-20T00:00:00Z